Cogent Biosciences Grants 22,000 Stock Options, 16,500 RSUs to Six New Employees
Bitget2026/10/27 20:01- Cogent Biosciences granted equity awards to six new employees on October 26, 2026, under its 2020 Inducement Plan.
- The awards comprised nonqualified options to purchase 22,000 common shares and 16,500 restricted stock units.
- Options have 10-year terms, with 25% vesting on the grant date's first anniversary.
- Remaining options vest in equal monthly installments over the subsequent 36 months; restricted stock units vest annually in equal installments over four years.
- All vesting requires continued employment through each vesting date.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AI Cloud Sector Faces a Key Moment: CoreWeave (CRWV.US) Set to Announce Earnings, Wells Fargo Remains Bullish
CoreWeave (CRWV.US) will release its third-quarter financial report after the U.S. stock market closes on Tuesday. This is seen as a key test for the strength of the new AI cloud sector.
JPMorgan raises target prices for Target and Walmart
Orient Precision Industries Holds Extraordinary Shareholders Meeting
Citi optimistic about international oil companies: low-cost resource reserves being rebuilt may drive energy sector to reverse a decade-long valuation discount
With oil prices in the mid-$70s range, Citi believes that global international oil companies (IOCs) can deliver a free cash flow yield of 7% to 8%, and achieve a real growth rate of 4% to 5% over a period of time.
Crypto prices
More
